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Abstract The genome sequence of Mycobacterium tuberculosis
(and also M. leprae) revealed a significant number of homologies
to Saccharomyces cerevisiae sterol biosynthetic enzymes. We
addressed the hypothesis of a potential sterol biosynthetic
pathway existing in Mycobacterium using cultures of Mycobac-
terum smegmatis. Non-saponifiable lipid extracts subjected to
analysis by gas chromatography-mass spectrometry (GC-MS)
showed cholesterol was present. Sterol synthesis by M.
smegmatis was confirmed using 14C-radiolabelled mevalonic
acid and incorporation into C4-desmethyl sterol co-migrating
with authentic cholesterol on TLC. The sterol biosynthetic
pathway has provided a rich source of targets for commercially
important bioactive molecules and such agents represent new
opportunities for Mycobacteria chemotherapy.
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1. Introduction
The genus Mycobacterium comprises a wide array of patho-
genic species, which includes Mycobacterium tuberculosis (tu-
berculosis), Mycobacterium leprae (leprosy), and Mycobacte-
rium bovis. Additionally, a number of Mycobacterium spp.
found in soil and water can cause systemic disease in severely
immuno-compromised people, especially AIDS patients.
Sterols in all living organisms are synthesised from acetic
acid via mevalonic acid and squalene (as key intermediates)
[1]. Lanosterol is the ¢rst cyclisation product in mammals and
fungi, while plants produce cycloartenol instead of lanosterol.
The ¢nal sterol products are cholesterol in mammals, ergo-
sterol in fungi and phytosterols in plants [2]. Sterols are in-
dispensable components in eukaryotic organisms for stabilis-
ing membranes composed of phospholipid bilayers. They have
also been implicated as having a hormonal role, the so-called
‘sparking role’ in yeast proliferation [3] and act as meiosis
activating factor (MAS) in mammals [4]. Prokaryotic organ-
isms, on the other hand, do not contain sterols in their mem-
branes, although previous studies indicated that the bacterium
Methylococcus capsulatus produces sterols [5,6] and many
strains of Mycoplasma, bacteria without cell walls, require
sterols as an essential growth factor [6,7]. A report of sterols
occurring in Escherichia coli has been made erroneously since
it has no cytochrome P450 [8]. Some bacterial species synthe-
sise hopanoids, which are thought to function like sterols in
eukaryotic organisms [9].
The recently completed genome sequence of Mycobacterium
tuberculosis [10] revealed one gene to be homologous to the
sterol 14K-demethylase biosynthetic enzyme (34% homolo-
gous at the amino acid level). Recently an activity of this
enzyme as a sterol demethylase has been reported in abstract
form [11]. Our interest in sterol biosynthesis coupled to the
knowledge that the most complete set of genes encoding struc-
tural enzymes of sterol biosynthesis exists for Saccharomyces
cerevisiae led us to search for homologies in M. tuberculosis.
This revealed a signi¢cant number of homologies in the M.
tuberculosis genome to the yeast sterol biosynthetic enzymes.
These included Rv 3823 (50% to HMG CoA reductase); Rv
1745 (46.9% to isopentenyl pyrophosphate isomerase) ; Rv
3383c (39.1% to farnesyl pyrophosphate synthetase); Rv
3397 (32.9% to squalene synthase) and Rv 1814 (24% to sterol
C5-desaturase). In the present paper, we addressed the hy-
pothesis of a sterol biosynthetic pathway in Mycobacterium
using cultures of Mycobacterium smegmatis, which can be
cultured in volume more safely.
2. Materials and methods
2.1. Strains
Mycobacterium smegmatis (Trevisan) Lehmann and Neumann
(strain NCTC 10265 (09)) was obtained from the National Collection
of Type Cultures, The Public Health Laboratory Service, London.
2.2. Chemicals
Unless speci¢ed all chemicals were obtained from Sigma, Poole,
Dorset, UK.
2.3. Growth conditions
A single isolated colony of M. smegmatis, obtained from plate
culture, was placed into 10 ml modi¢ed LB medium consisting of
2% (w/v) Difco Bactopeptone, 0.5% (w/v) Difco yeast extract and
0.5% (w/v) sodium chloride and incubated at 37‡C with shaking
(225 rpm) overnight. Subsequently, 500 ml of the modi¢ed medium
contained in a 2-l £ask was inoculated with 5 ml of the overnight
culture and grown at 37‡C with shaking to saturation.
2.4. Identi¢cation of sterols by GC-MS
Samples for gas chromatography-mass spectrometry (GC-MS) were
prepared from 500-ml cultures in growth conditions as described
above. Cells were harvested by centrifugation at 1500Ug. The cell
pellet was saponi¢ed in 15% (w/v) KOH in 90% (w/v) ethanol at
80‡C for 1 h. Non-saponi¢able lipids (sterols and sterol precursors)
were extracted with 3U5 ml heptane and dried under nitrogen. Fol-
lowing silylation for 1 h at 60‡C with BSTFA (50 Wl) in 50 Wl of
toluene, sterols were analysed by GC-MS (VG 12-250 (VG Biotech)
using split injections with a split ratio of 20:1. Sterol identi¢cation
was by reference to relative retention time and mass spectra as re-
ported previously [2,12].
2.5. Synthesis of [14C]cholesterol from [2-14C]mevalonic acid
[2-14C]Mevalonic acid (100 Wl ; 0.25 WCi) was added to 500 ml
modi¢ed LB medium prior to the addition of the overnight culture
of M. smegmatis. Cultures were incubated for 24 h at 37‡C with
shaking (150 rpm). Non-saponi¢able lipids (sterols and sterol precur-
sors) were isolated as described above, extracted with hexane and
dried under nitrogen. The non-saponi¢able lipid was applied to silica
gel thin layer chromatography (TLC) plates (ART 573, Merck) and
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developed using toluene/diethyl ether, 9:1 (v/v). Radioactive sterol
was located by autoradiography, identi¢ed by comparison following
co-chromatography of known standards and excised for scintillation
counting.
3. Results
Fig. 1 shows the GC-MS spectrum obtained following anal-
ysis of non-saponi¢able lipid (sterol and sterol precursors)
extracted from 500 ml culture of M. smegmatis. Surprisingly
for this prokaryotic organism, a predominant sterol identi¢ed
as cholesterol was observed in the extract, which was con-
¢rmed by mass spectral analysis compared to authentic chol-
esterol standard and cholesterol co-chromatographic studies.
Minor peaks representing cholesterol derivatives, including
dimethylcholesterol, were also observed. Cholesterol was
found to be only a minor constituent of the bacterial cell
representing 0.001 mg/g dry cell weight. These results con¢rm
the hypothesis of the presence of a sterol biosynthetic path-
way in M. smegmatis and are consistent with the presence of
predicted Mycobacterium sterol biosynthetic enzymes.
Con¢rmatory evidence for the presence of a cholesterol
biosynthetic pathway within M. smegmatis was also obtained
from radiolabel feeding experiments utilising one of the ear-
liest precursor molecules within the sterol pathway, namely
[2-14C]mevalonic acid. Fig. 2 shows the results of such experi-
ments, which reveal that growing M. smegmatis could utilise
[2-14C]mevalonic acid, and incorporate radiolabel into a C4-
desmethyl sterol ([14C]cholesterol).
4. Discussion
The synthesis of cholesterol is a metabolically expensive
process. Due to the metabolic cost to the organism, cholester-
ol is likely to be an essential cellular component for it to have
emerged and persisted as a cellular constituent during the
evolution of Mycobacterium smegmatis. Consequently, the
ability of the Mycobacteria genus to synthesise sterol endoge-
nously and its functional role within the bacterial cell is in-
triguing. Cholesterol is the predominant sterol in all mamma-
lian cells, is a vital constituent of cell membranes and the
precursor of steroid hormones and bile acids. However, chol-
esterol was shown to be only a minor sterol constituent within
M. smegmatis. Thus, the role of cholesterol to the cell deserves
further clari¢cation.
Ergosterol, the principal sterol in most fungi, is an indis-
pensable component in membrane structures [13]. The anti-
fungals developed in the pharmaceutical and agrochemical
sectors have targeted the ergosterol biosynthetic pathway to
cause inhibition of ergosterol synthesis in fungi and ultimately
cell growth arrest. Inhibitors of 14K-demethylation of lano-
sterol and 24-methylene-24,25-dihydrolanosterol are the most
widely discovered class of sterol biosynthesis inhibitors [14];
they include substituted pyrimidines, pyridines, piperazines,
triazoles and imidazoles. Morpholines are the second class
of inhibitors; they inhibit v8Cv7 isomerisation (the conver-
sion of fecosterol to episterol) and block v14 reduction [15].
Further commercial antifungal drugs target squalene epoxi-
dase (allyamines) [16]. Large e¡orts have also been made to
FEBS 20977 19-10-98
Fig. 1. GC-MS analysis of trimethylsilated derivatised non-saponi¢able lipid extracted from M. smegmatis grown on modi¢ed L-broth, as de-
scribed in Section 2. Cholesterol was the most abundant sterol detected by gas chromatography (a) and identity was con¢rmed from the mass
spectrum (b).
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develop anti-cholesterol agents inhibiting HMG CoA reduc-
tase (pravastatin) [17] and other steps of sterol biosynthesis.
New therapeutic compounds are needed urgently due to the
emergence of drug resistant isolates of M. tuberculosis and the
increased incidence of such infections in immunocompromised
patients. Sterol biosynthesis inhibitors may represent an alter-
native strategy for combating this disease and the many ex-
isting drugs and experimental compounds are an attractive
prospect for developing proof of this hypothesis.
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Fig. 2. Autoradiogram after TLC separation of non-saponi¢able lip-
id extract of M. smegmatis utilising [2-14C]mevalonic acid, and
showing incorporation of radiolabel into a C4-desmethyl sterol
([14C]cholesterol).
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